We're not just engineers, scientist, strategists, researchers who are only looking to develop the opportunities to help eradicate diseases from the world, but we're all change agents that are looking to bring inclusivity to clinical trials. Many clinical trials programs have less than 2% of minorities that enroll and even less that actually stay during the duration. We're bringing the clinical trials to the patient where they live.